Icon

SYMJEPI (nda207534)- (0.15MG/0.3ML (0.15MG/0.3ML),0.3MG/0.3ML (0.3MG/0.3ML))

EPINEPHRINE ADAMIS PHARMS CORP
0.15MG/0.3ML (0.15MG/0.3ML),0.3MG/0.3ML (0.3MG/0.3ML)
No Yes
2036-Oct-20 Expired
None None
None No
SYMJEPI is a non-selective alpha and beta-adrenergic receptor agonist, indicated in the emergency treatment of allergic reactions (Type I) including anaphylaxis.
0 0 0
Total Other Developers 1
Drugs with Suitability No
0.15MG/0.3ML (0.15MG/0.3ML) ** ** - - -
0.3MG/0.3ML (0.3MG/0.3ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.